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ABSTRACT 1 
 2 
Objectives: Epilepsy in humans and rodent models of epilepsy can be associated with 3 
behavioural comorbidities including an increased prevalence of attention-deficit/hyperactivity 4 
disorder (ADHD). ADHD symptoms and seizure frequency have been successfully reduced in 5 
humans and rodents using a ketogenic diet (KD). The aims of this study were (i) to describe 6 
the behavioural profile of dogs with idiopathic epilepsy (IE) while on a standardised non-7 
ketogenic placebo diet, to determine whether ADHD-like behaviours are present, and (ii) to 8 
examine the effect of a ketogenic medium chain triglyceride diet (MCTD) on the behavioural 9 
profile of dogs with idiopathic epilepsy (IE) compared to the standardised placebo control diet, 10 
including ADHD-like behaviours.  11 
Methods: A 6-month prospective, randomised, double blinded, placebo controlled, crossover 12 
dietary trial comparing the effects of the MCTD to a standardised placebo diet on canine 13 
behaviour was carried out. Dogs diagnosed with IE, with a seizure frequency of at least 3 14 
seizures in the past 3 months (n=21), were fed the MCTD or placebo diet for 3 months, then 15 
were switched to the alternative diet for 3 months. Owners completed a validated behavioural 16 
questionnaire to measure 11 defined behavioural factors at the end of each diet period to report 17 
their dogs’ behaviour, with three hypothesised to be related to ADHD: excitability, chasability 18 
and trainability.  19 
Results: The highest scoring behavioural factors in the placebo and MCTD period were 20 
excitability (mean ± SE: 1.910±0.127), and chasing (1.824±0.210). A markedly lower 21 
trainability score (0.437±0.125) than previously studied canine populations was observed. The 22 
MCTD resulted in a significant improvement in the ADHD-related behavioural factor chasing, 23 
and a reduction in stranger-directed fear (p<0.05) compared to the placebo diet. The latter effect 24 
may be attributed to previously described anxiolytic effects of a KD.  25 
Conclusions: This data supports the supposition that dogs with IE may exhibit behaviours that 26 
resemble ADHD symptoms seen in humans and rodent models of epilepsy, and that a MCTD 27 
may be able to improve some of these behaviours, along with potentially anxiolytic effects. 28 
 29 
 30 
 31 
 32 
Key words: canine; attention-deficit/hyperactivity disorder; ketogenic; medium chain 33 
triglyceride; comorbidity; anxiolytic 34 
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 35 
List of abbreviations 36 
 37 
ADHD: Attention Deficit Hyperactive Disorder 38 
AED: Anti-Epileptic Drug 39 
AKC: American Kennel Club 40 
C-BARQ: Canine Behavioural Assessment and Research Questionnaire 41 
CPRS-R: Conners’ Parent Rating Scale 42 
IE: Idiopathic Epilepsy 43 
KD: Ketogenic Diet 44 
MCTD: Medium Chain Triglyceride Diet 45 
MRI: Magnetic Resonance Imaging 46 
QoL: Quality of Life 47 
  48 
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1. Background 49 
 50 
1.1 ADHD and Epilepsy 51 
 52 
Psychiatric disorders are common in human patients with epilepsy, with attention-53 
deficit/hyperactivity disorder (ADHD) being one of the most common co-occurring disorders 54 
alongside depression and anxiety. Up to one third of epilepsy patients are diagnosed with 55 
ADHD [1]. In a recent large-scale community-based survey, ADHD symptoms were reported 56 
in nearly one of five adults with self-reported epilepsy, which was associated with increased 57 
psychosocial morbidity and lowered quality of life (QoL) [2]. The hypothesised association 58 
between epilepsy and ADHD is not recent; a ‘hyperkinetic syndrome’ was described in child 59 
epilepsy patients which resembles current definitions of ADHD nearly 60 years ago [3]. 60 
Attention/associative deficits combined with impulsivity and hyperactivity are the defining 61 
features of ADHD [4].  62 
 63 
Hyperactivity is 5.7 times more prevalent in children with epilepsy than control children [5]. 64 
ADHD affects children and adolescents, with symptoms often persisting into adulthood [6].  65 
Significant ADHD symptoms are present in many patients before the onset of the first seizure. 66 
Of children newly diagnosed with epilepsy, 31% showed symptoms of ADHD [7], with 82% 67 
of these children with epilepsy and ADHD showing ADHD symptoms prior to seizure onset 68 
[7]. A bidirectional association between epilepsy and ADHD has been demonstrated, with 69 
epilepsy patients at an increased risk of ADHD, and ADHD patients at an increased risk of 70 
epilepsy. For example, in a population-based cohort study of Taiwanese children <19 years 71 
old, the possibility of developing ADHD in epilepsy patients was significantly higher (adjusted 72 
hazard ratio 2.54), and the possibility of developing epilepsy in ADHD patients was also 73 
significantly higher (adjusted hazard ratio 3.94) [8]. 74 
  75 
1.2 Animal models of epilepsy and ADHD 76 
 77 
The link between seizure activity and ADHD-like behaviours is not limited to human epilepsy. 78 
Hallmarks of ADHD (e.g. easy distraction and slow learning) have been demonstrated in a 79 
strain of epilepsy-prone laboratory rats using various behavioural paradigms with a disinhibited 80 
or impulsive behavioural style [9]. This has been thought to establish the disorders as truly 81 
comorbid [10]. In a rat model of temporal lobe epilepsy, a fast-kindling selectively bred strain 82 
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(‘Fast’ rats) exhibit different behavioural features from slow-kindling rats (‘Slow’ rats). Fast 83 
rats show signs such as hyperactivity, impulsivity and easy distraction compared to Slow rats 84 
[11]. Fast rats are comparatively hyperactive in an open field exploration task [12], and when 85 
restrained, struggle far longer and with more ferocity than Slow rats, indicating a higher level 86 
of hyperactivity/impulsivity [13]. High levels of impulsivity and distractibility may result in 87 
learning deficits. In a delayed alternation test Fast rats displayed a high degree of impulsivity 88 
and learning deficits  [14]. In addition, in several variants of a Morris water maze, Fast rats 89 
were more likely to be distracted by irrelevant cues during acquisition [9]. Fast rats appear to 90 
retain more juvenile like features [15], with impulsivity, distractibility and reduced fear than 91 
typically shown in juvenile mammals [16]. In addition, Fast rats also exhibit age-inappropriate 92 
juvenile and aggressive play behaviours that are not seen in Slow rats [15]. 93 
 94 
1.3 Epilepsy and canine behaviour 95 
 96 
Epilepsy is a common chronic neurological disorder in dogs as well as humans, with an 97 
estimated prevalence in dogs of 0.6 in the first opinion practice population [17]. The dog also 98 
shows some similar aspects of human behaviour, possibly owing to the similarity of 99 
evolutionary processes that have shaped their behaviour [18]. Parallels have been drawn 100 
between behavioural disorders in humans and canines, such as separation anxiety and 101 
obsessive-compulsive disorder [19]. Although parallels between childhood ADHD and canine 102 
activity and attention-related behavioural problems have been considered [20], the behavioural 103 
profiles of dogs with epilepsy has been little studied thus far, despite being considered as a 104 
naturally occurring model of human epilepsy [21, 22]. In a recent single-breed study of Lagotto 105 
Romagnolo dogs with or without a history of Benign Familial Juvenile Epilepsy (BFJE;  where 106 
dogs often experience spontaneous seizure remission before 13 weeks of age), dogs with BFJE 107 
(n=25) showed significantly higher scores on the behavioural factors ‘Inattention’ and 108 
‘Excitability/Impulsivity’ than did the control group without BFJE [23]. The authors 109 
considered these behaviours to be comparable with ADHD in humans. These behavioural 110 
changes were observed after at least four years following the last observed seizure, which 111 
demonstrates that behavioural comorbidities can be present in the absence of seizure activity. 112 
As this study was limited to one breed with one specific type of epilepsy, whether these results 113 
are more widely applicable to the canine IE population is unknown, as different epilepsy 114 
syndromes may pose different risks for behavioural development problems. 115 
 116 
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1.4 The influence of diet on behaviour 117 
External factors associated with diet and the dog’s lifestyle may also have an impact upon the 118 
seizure activity and behaviour. Diet induced behavioural modifications in dogs have been 119 
reported in peer-reviewed literature and anecdotal notes [24]. For example, a low protein diet 120 
has been shown to reduce certain types of aggression in dogs [25, 26], and supplementation of 121 
casozepine or the proportion of protein in a given diet may reduce anxiety-related behaviour 122 
[27]. The ketogenic diet (KD), which is a high fat, low protein, and low carbohydrate diet used 123 
in the treatment of intractable human epilepsy, also appears to improve symptoms of ADHD 124 
in individuals with both disorders in humans. For example, the KD can decrease seizure activity 125 
or lead to seizure freedom in children refractory to anti-epileptic drug (AED) therapy allowing 126 
reduction or cessation of medication [28, 29]. The KD has also been found to decrease ADHD 127 
symptoms in both adults and children [30-33]. This improvement in ADHD symptoms appears 128 
to be independent of seizure control, with behaviour found to improve even if seizure control 129 
is not obtained [30, 31]. Similar effects on behaviour have also been investigated in laboratory 130 
rodents, where reversible reductions in activity are observed [34].  131 
 132 
Around 20–30% of dogs with IE will remain poorly controlled (<50% reduction of seizure 133 
frequency) despite adequate treatment with common first and second line AEDs 134 
phenobarbitone (PB) and/or potassium bromide (KBr) [35-37]. Consequently, there is a need 135 
for further treatment options, particularly for pharmacoresistant patients. A novel diet with 136 
relatively low MCT levels (MCTD) was recently developed for canine cognitive function and 137 
shown to be ketogenic [38]. To date, this diet has been found to have a cognition-enhancing 138 
effect in aged dogs [38], and show antiepileptic properties [39].   139 
The aims of this study were twofold: 140 
1. To describe the behavioural profile of dogs with IE while on a standardised diet, to 141 
determine whether ADHD-like behaviours are present in this population 142 
2. To examine the effect of a ketogenic MCTD on the behavioural profile of dogs with IE 143 
compared to the standardised placebo control diet, including ADHD-like behaviours 144 
 145 
2. Methods 146 
 147 
2.1 Study design 148 
 149 
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The present study comprised of a 6-month prospective, randomised, double blinded, placebo 150 
controlled, crossover dietary trial comparing the effects of the MCTD to a standardised placebo 151 
diet on behaviour in canine epilepsy. Dogs were fed either the MCTD or placebo diet for 3 152 
months (Day 1 to Day 90 ±2 days) followed directly by a subsequent respective switch of diet 153 
for a further 3 months (Day 90 to Day 180 ±2 days).  154 
 155 
2.2 Recruitment of cases 156 
 157 
Owners of dogs with IE were recruited by contacting primary care veterinary practices to 158 
identify cases and through social media e.g. canine epilepsy support groups. These dogs were 159 
recruited for a study investigating the efficacy of a diet on seizure reduction, with the dual aim 160 
of examining their behavioural profile during the study. As such, specific inclusion and 161 
exclusion criteria were employed. Dogs were deemed suitable for inclusion in this study if they 162 
were of mixed or pure breed status and met the following requirements: 163 
(i) Had IE: unremarkable former magnetic resonance imaging (MRI) scan and 164 
cerebrospinal fluid (CSF) analysis; no clinically significant findings on 165 
haematology, biochemistry or bile acid results; unremarkable interictal neurological 166 
examinations for dogs on antiepileptic treatment; 167 
(ii) Were between 6 months and 12 years of age;  168 
(iii) Weighed between 4kg and 65kg; 169 
(iv) Had at least 3 seizures in the 3 months prior to start of study; 170 
(v) Were being treated chronically with at least one antiepileptic treatment;  171 
Dogs were excluded from the study if they were: 172 
(i) Were receiving drugs that could influence the metabolism of PB and KBr; 173 
(ii) Were intended for breeding less than two weeks from start of study, or were females 174 
known or suspected to be pregnant or lactating; 175 
(iii) Had a known cause of epilepsy such as brain neoplasm, brain trauma, encephalitis 176 
and meningitis;  177 
(iv) Were affected by chronic or acute renal, hepatic or cardiac failure;  178 
(v) Had an acute or surgical condition at the time of enrolment 179 
 180 
Only one dog per household was allowed in the study to maintain independence. A unique 181 
Study Case Number (SCN), consisting of a two-digit number ascending in a chronological 182 
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order of enrolment, was allocated and used to identify each dog on all documents and samples 183 
throughout the study.  184 
 185 
2.3 Diet 186 
 187 
Full details of each diet are available in Law et al [40]. The experimental placebo and test 188 
formulas were dry extruded kibble (Nestle Purina PetCare, St. Louis, Missouri, USA) 189 
formulated to meet or exceed nutritional guidelines established by the Association of American 190 
Feed Control Officials. Both formulas were of the same nutrient composition, and formulated 191 
to contain less than 10% moisture, at least 28% crude protein (as fed basis), at least 15% crude 192 
fat (as fed basis), less than 6% ash (as fed basis), and  less than 2% as crude fiber (as fed basis). 193 
The one composition exception is that zero MCTs were added to the placebo formula, and lard 194 
was used as fat substitute to ensure that the formulas were isocaloric (373 kcal/100 g), whereas 195 
the test formula contained 5.5% MCTs. MCT content was about 10% of total formula calories 196 
(based on fat as 8.5 kcal/g and MCT as 6.8 kcal/g).  All dogs were housed indoors and the 197 
majority were fed once/day, with no restrictions on water consumption. The owners were 198 
educated to keep diet consistent throughout the study period. Amount of food given per day 199 
was calculated according to the weight for each dog to provide sufficient nutritional needs. A 200 
deviation of ±10% food consumption (kg) was allowed to account for the individual needs of 201 
each dog taking into consideration differences in activity level and physical condition. Dogs 202 
were restricted to consumption of only study food, hence treats or snacks were replaced by the 203 
respective placebo or MCTD food.  204 
 205 
2.4 Behavioural data 206 
 207 
At the end of each three month period (placebo or MCTD), owners were asked to complete a 208 
previously validated behavioural questionnaire to report on their dog’s behaviour during that 209 
period, the C-BARQ [41] (Supplementary Table 1). The C-BARQ was chosen to quantify the 210 
behavioural profiles of dogs during both diet periods as it has been validated [41], studied in 211 
international canine populations, and covers a broad range of behaviours. Although aim (1) of 212 
this study focuses on ADHD-like behaviours, quantifying changes in other behaviours is 213 
important when testing a novel diet, to detect any unexpected effects.  214 
 215 
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The questionnaire comprises 68 questions, owners are asked to score their dogs on either a 5-216 
point frequency scale (i.e. 0= never - 4=always) for particular responses e.g. attention-seeking 217 
behaviour, or a 5-point qualitative rating scale (i.e. 0=no signs of behaviour – 4=severe signs 218 
of the behaviour) for intensity of behaviours e.g. excitability. If owners were unable to answer, 219 
an ‘N/A’ option was included, which was treated as missing data in the analyses. Behaviours 220 
were previously grouped into 11 broad categories using factor analysis: ‘stranger-directed’ 221 
aggression; ‘owner-directed’ aggression; ‘stranger-directed’ fear; non-social fear; ‘dog-222 
directed’ fear; ‘separation-related’ behaviour; attachment or attention seeking behaviour; 223 
trainability; chasing behaviour; excitability; and touch sensitivity. The loading factors for each 224 
question established in the validation study were used for the analysis of each category. 225 
 226 
Children diagnosed with ADHD frequently have unusually high activity and emotional 227 
reactivity, and may be more distractible and impulsive [42]. As such, from the C-BARQ 11 228 
behavioural factors, we would expect to observe relatively high levels of the following factors 229 
compared to other factors, and compared to ‘normal’ dogs: 230 
(i) Excitability: dogs with high scores for this factor have strong reactions to exciting events 231 
and have difficulty calming down after events [41] which may resemble high emotional 232 
reactivity and excitability seen in ADHD. The revised Conners’ Parent Rating Scale 233 
(CPRS-R) [43] is a popular research and clinical tool for obtaining parental reports of 234 
childhood behaviour problems. It includes ‘excitable’ as a component of the 235 
hyperactivity-impulsivity score. Another component measured in the CPRS-R 236 
hyperactivity-impulsivity score is ‘difficulty waiting’ which may resemble components 237 
of the Excitability factor, namely a dog being ‘excitable just before being taken for a 238 
walk’ and ‘excitable just before being taken on a car trip’. 239 
(ii) Chasing: dogs with high scores for this factor have a tendency to chase cats, birds, 240 
squirrels and/or other small animals [41] which may indicate a degree of hyperactivity 241 
seen in ADHD. The CPRS-R includes the components ‘runs excessively’, ‘restless’ and 242 
‘always on the go’ in the hyperactivity-impulsivity score [43] which the Chasing factor 243 
may resemble. 244 
Conversely, we would expect to observerelatively low levels of: 245 
(i) Trainability: dogs with low scores are not attentive to their owners or willing to obey 246 
basic commands, are easily distracted, do not tend to be fast learners, and do not tend 247 
to retrieve thrown objects/toys [41], which may resemble impaired attention resulting 248 
in learning deficits.  249 
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 250 
2.5 Clinical data 251 
 252 
In addition, seizure frequency, seizure days, body weight and measurements of serum PB 253 
and/or KBr concentration as appropriate were recorded for each dog. Visual analogue score 254 
(VAS) for ataxia, sedation and quality of life (QoL) were recorded by the owner, using a line 255 
ranging from 0mm to 100mm. The owner was asked to draw a secondary intersecting line, 256 
perpendicular to the line of measurement that best represented the subjective severity. A 257 
perpendicular line at 0mm represented either asymptomatic/normal and at 100mm represented 258 
either ‘ataxia so severe dog is unable to walk’, ‘sedation to the extent dog only sleeps’ and 259 
extremely poor ‘QoL, respectively.   260 
 261 
2.6 Ethics statement 262 
 263 
This study was conducted in accordance with the guidelines laid down in the International 264 
Cooperation of Harmonization of Technical Requirements for Registration of Veterinary 265 
Products (VICH) GL9 Good Clinical Practices (GCP) and the European Agency for the 266 
evaluation of Medical Products (EMEA). The study protocol was approved by the Royal 267 
Veterinary College’s Ethics and Welfare Group (EWG) (URN 2011 1132). The owners of the 268 
dogs gave consent for their animals to be used in this study. 269 
 270 
2.7 Statistical analysis 271 
 272 
Weighted scores for the 11 behavioural factors were calculated for each dog using the loading 273 
factors for each question established in the validation study, with descriptive statistics 274 
calculated for each factor. Wilcoxon Signed Rank tests were used to compare the differences 275 
in behavioural factors between diet groups. Spearman’s rank test was used to test for 276 
correlations between the behavioural factors and seizure frequency, PB/KBr levels, and VAS 277 
scores for ataxia, sedation and QoL. The Kruskall-Wallis test was used to test for associations 278 
between behaviour and breed, and the Mann-Whitney U test used to test for associations 279 
between behaviour and gender, neuter status and the presence of cluster seizures. All tests were 280 
two-sided and P < 0.05 was considered to be significant. Data are presented as mean ± standard 281 
deviation (SD), or median (25th-75th quartile), where appropriate. 282 
 283 
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3 Results 284 
 285 
3.1 Population demographics 286 
 287 
Twenty-one dogs of 17 breeds and three cross breeds were included in the study. Ten dogs 288 
were neutered male, five entire male, four neutered female and two entire female. The mean 289 
age was 4.59 ±1.73 years of age and mean weight 29.79 ±14.73 kg. All 21 dogs received PB, 290 
and the majority (n=18) were also treated with KBr. The mean serum concentrations of PB was 291 
31.05ug/ml±6.36, and mean potassium bromide was 1.05mg/ml±0.71. Several dogs were 292 
chronically treated with a third AED, imepitoin (n=1) or levetiracetam (n=8). 3 dogs were 293 
treated with 1 AED, 11 with 2 AEDs, and 7 with 3 AEDs. To avoid confounding influences, 294 
concomitant AED medication and dosages were unchanged throughout the study.  Twelve 295 
owners had been prescribed rectal diazepam or levetiracetam for pulse therapy by their first 296 
opinion vet for at home treatment of cluster seizure episodes. The mean age at first seizure 297 
event was 27.85 months (SD: 23.16). Three dogs were outside of the ‘>6 month to <6 year age 298 
bracket at seizure onset. recognized to be indicative of idiopathic epilepsy in dogs [44]. As is 299 
recommended in this circumstance, all dogs underwent MRIs that were found to be clear of 300 
structural abnormalities and thus were diagnosed with idiopathic epilepsy. Nine dogs 301 
experienced cluster seizures and twelve experienced only single seizures. Full details of 302 
demographics are available in the original study of the effect of the MCTD on seizure 303 
frequency [39]. 304 
 305 
3.1 Baseline behaviour: Placebo diet 306 
 307 
The highest scoring behavioural factors in the placebo period were excitability (mean ± SE: 308 
1.910±0.127) and chasing (1.824±0.210). Regarding the individual questions that constitute 309 
each factor, for excitability, over half of dogs (52.38%) were reported to act in an ‘extremely 310 
excitable’ way (score 4 on a scale of 0-4) when a member of the household returns after a brief 311 
absence, when playing with a member of the household and just before being taken for a walk. 312 
A further 47.62% act in an ‘extremely excitable’ way before being taken on a car trip, 42.86% 313 
when visitors arrive at the home, and 33.33% when the doorbell rings. For chasing, over half 314 
of dogs (52.38%) were reported to ‘always’ chase squirrels and other small animals if given 315 
the chance, nearly half ‘always’ (47.62%) chase cats, and a third (33.33%) ‘always’ chase birds 316 
or act aggressively to cats, squirrels, and other animals entering their garden.  317 
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 318 
In contrast, the ‘trainability’ behavioural factor was relatively low (0.437±0.125).  Two thirds 319 
of owners (66.67%) reported that their dog is ‘always’ easily distracted by interesting sights, 320 
sounds and smells. In contrast, less than one quarter (23.81%) dogs would ‘always’ obey a sit 321 
command, and less than a tenth (9.52%) obey a stay command immediately.  322 
 323 
The baseline median seizure frequency per month during the placebo diet phase was 2.67 324 
seizures/month (1.78-4.91), and the median seizure days per month was 1.69 days/month (1.16-325 
3.30). The mean VAS score for ataxia was 42.38 ± 16.48, sedation 38.19 ± 4.37, and QoL 326 
31.14 ± 18.24. No associations were found between the ADHD-related behavioural factors 327 
(excitability,chasing and trainability) and clinical variables (e.g. seizure frequency, experience 328 
of cluster seizures, VAS scores for ataxia and sedation).  329 
 330 
3.2 MCTD 331 
 332 
The median seizure frequency per month in the MCTD period was 2.31 seizures/month (1.00-333 
4.46), and the median seizure days per month was 1.63 days/month (0.67-2.32). As previously 334 
reported [39], seizure frequency was significantly lower when dogs were fed the MCTD in 335 
comparison to placebo diet (p<0.05).  336 
 337 
The highest scoring behavioural factors in the MCTD period were again excitability (mean ± 338 
SD: 1.863±0.136) and chasing (1.516±0.200). Two behavioural factors differed significantly 339 
between the placebo diet and MCTD phases (Table 1). Significant reductions in one of the 340 
ADHD-related factors, chasing behaviour (p=0.037) was observed when dogs were on the 341 
MCTD in comparison to the placebo diet, but not excitability (Table 1, Figure 1). A reduction 342 
in stranger-directed fear was also observed during the MCTD in comparison to the placebo diet 343 
(p=0.046). There were no significant changes in stranger-directed aggression, owner-directed 344 
aggression, dog-directed fear, separation-related behaviour, non-social fear, attachment or 345 
attention seeking behaviour, trainability, excitability, and touch sensitivity behavioural factors 346 
between diet groups. 347 
 348 
The mean VAS score for ataxia was 41.05 ± 20.21, sedation 38.62 ± 23.03, and QoL 28.29 ± 349 
18.78. No associations were again found between the ADHD-related behavioural factors 350 
(excitability,chasing and trainability) and clinical variables (e.g. seizure frequency, experience 351 
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of cluster seizures, VAS scores for ataxia and sedation). As such, the reductions in chasing 352 
were not thought to be due to an increase in sedation or ataxia inhibiting these behaviours. 353 
There was no effect of the number of AEDs a dog was treated with on any of the behavioural 354 
factors in either diet period, or changes in seizure frequency. 355 
 356 
4. Discussion 357 
 358 
The data presented show that (i) behaviours observed in dogs with IE resemble those seen in 359 
humans and rodent models of epilepsy, with relatively high levels of excitability and chasing 360 
behaviour, and relatively low levels of trainability and (ii) the MCTD significantly reduces one 361 
of these behavioural factors ‘chasing’, and reduced stranger directed fear. This study adds 362 
further evidence to the notion that there may be common neurobiological mechanisms present 363 
in epilepsy and ADHD. Although direct comparisons between specific behaviours are not 364 
possible between humans, rats and dogs, the profile of excitability, a propensity towards active 365 
chasing behaviour, and a reduced ability to learn because of distraction resembles the 366 
behaviours described in individuals of these species with epilepsy-related ADHD.  367 
 368 
The trainability of this population when compared to average trainability values of healthy dogs 369 
are markedly lower, with the average score ~2.5 in the 30 most popular American Kennel Club 370 
(AKC) registered breeds [45], but just 0.437 in this study. The MCTD diet was associated with 371 
an increase in trainability, from 0.437 to 0.600; however, this difference was not significant. 372 
Even within the MCTD period, trainability did not increase to ‘normal levels’ seen in the AKC 373 
population study [45]. No change was observed in the behavioural factor excitability, 374 
hypothesised to be ADHD-related. As such, further research may be required to investigate 375 
why the MCTD differentially affects these potential components of an ADHD–like behavioural 376 
profile, and whether further interventions such as behavioural therapy or obedience training are 377 
required to further increase trainability and reduce excitability. 378 
 379 
4.1 Effect of diet 380 
 381 
Studies in rat models of epilepsy have previously demonstrated positive effects of diet on 382 
ADHD symptoms [34, 46]. To date there have been no studies investigating the relationship 383 
between diet, seizure activity and behaviour in dogs. The present study is the first to present 384 
significant results showing dietary induced behavioural modifications in dogs with epilepsy. 385 
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KDs have been shown to not only control seizure activity in human patients with epilepsy, but 386 
also to improve behaviour in general [47]. Symptoms of ADHD have also been reported to 387 
decrease in both adults and children on a KD irrespective of level of seizure control [48]. 388 
Although the exact mechanisms involved with behavioural improvements and KDs are 389 
unknown it has been suggested that alterations of energy metabolism in the brain may 390 
contribute to behavioural changes [48].   391 
 392 
Increases in fear/anxiety have previously been documented in drug-naïve dogs with idiopathic 393 
epilepsy [49]. The reduction in stranger directed fear was unexpected in this study, and may 394 
indicate an anxiolytic effect of the MCTD. KDs such as the MCTD in this study have recently 395 
been shown to have anxiolytic effects. In a mouse model of Alzheimer’s disease, mice who 396 
were supplemented with a ketone ester, a precursor of the physiological forms of ketone bodies 397 
that increase during a KD, showed reduced anxiety in an elevated plus maze and open field 398 
testing [50]. Pilot study results have also shown reductions in some of the behavioural, social 399 
communication and cognitive deficits seen in children with autism on a KD[51]. The ketogenic 400 
MCTD utilised in this study has previously been demonstrated to improve the cognitive 401 
function of aged dogs, to be due to the diet providing the brain with an alternative energy source 402 
[38]. The significant behavioural improvements in stranger directed fear and chasing behaviour 403 
seen in this study gives credence to dietary modifications of behaviour and provides motivation 404 
for further investigations on the causal link between KDs and behavioural change. 405 
 406 
4.2 Identifying and quantifying ADHD-like behaviours 407 
 408 
These results are an early indicator of ADHD-like behavioural profiles in dogs with epilepsy, 409 
and thus must be taken as a preliminary descriptive finding. Further studies are required to 410 
compare dogs with epilepsy with healthy dogs to quantify the degree of behavioural 411 
abnormality in IE cases. Although one previous study identified ADHD-like behaviours in dogs 412 
with epilepsy when compared to healthy controls, this was limited to one breed with a specific 413 
type of epilepsy [23], and thus it’s broader applicability was unknown. Despite this limitation, 414 
the similar findings between that study and the present study indicate that this behavioural co-415 
morbidity may well be present in the dog. Both of these studies relied on pet-owner 416 
questionnaires of canine behaviour. To complement and strengthen the evidence of this 417 
comorbidity, direct objective behavioural observations should be employed to establish a 418 
relationship between ADHD and canine epilepsy, to avoid potential biases of owner-reporting. 419 
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The Activity-Impulsivity Behavioural Scale (AIBS) [52] is a four part behavioural test that is 420 
significantly correlated with the Dog ADHD rating scale (ADHD-RS), a questionnaire adapted 421 
from human psychology and developed in healthy dogs [20]. Levels of activity-impulsivity as 422 
quantified by the AIBS scale have been associated with the TH intron 4 polymorphism [52]. 423 
In addition to direct behavioural observation and tests, technology such as activity monitors 424 
[53] could also be used to quantify the degree of movement (and if present, hyperactivity) in 425 
these dogs compared to healthy controls of the same breed. 426 
 427 
4.3 AED side effects 428 
 429 
It is possible that some of the behaviours observed in this population were related to the AEDs 430 
the dogs were receiving, with the majority receiving both phenobarbital and potassium 431 
bromide. Both of these drugs can result in sedation and lethargy [54]; however, the mean score 432 
for sedation in this study was 38.19/100 (with 100 representing sedation to the extent dog only 433 
sleeps) and thus did not appear a major problem for these animals, with no correlation between 434 
VAS scores for sedation and QoL. It would be expected that sedation would reduce the ADHD-435 
like behavioural signs in these dogs, and thus this side effect would not explain the behavioural 436 
profile observed. There have been reports of restlessness and hyperactivity as side effects of 437 
the AED phenobarbital [55, 56].  In humans, AEDs associated with ADHD-like side effects 438 
include phenobarbital, gabapentin, vigbatrin and topiramate [57]. Canine literature in this area 439 
is sparse and whether these behaviours originate from the disease or as AED side effects has 440 
not yet been determined. If related to AEDs it would be expected that dogs would exhibit 441 
different behaviour profiles before and after AED treatment. It has further been noted that 442 
ADHD-like behaviours due to AEDs would be expected to change when medication 443 
type/dosage is altered, and as such clinical signs may be transient in contrast to true ADHD 444 
symptoms which are likely to be present and persistent from an early age [58]. Longitudinal 445 
studies are required to ascertain the temporal pattern of potential behaviour changes in these 446 
dogs. 447 
 448 
The dogs in this study were of a particularly severe epilepsy phenotype, with a median seizure 449 
frequency of 2.67 seizures/ month during the placebo phase despite treatment with PB and/or 450 
KBr, with over half experiencing cluster seizures. As such, whether the same behavioural 451 
profile would be seen in dogs that were more responsive to AED treatment is unknown, as only 452 
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20–30% of dogs with IE remain poorly controlled despite adequate treatment these AEDs [35-453 
37]. 454 
 455 
4.4 Influences on behaviour 456 
 457 
The behaviour of companion dogs is complex, with many potential internal and external factors 458 
impacting upon the behaviours observed by the owner. Previous studies have found that young 459 
dogs exhibit higher levels of attention-seeking behaviour and were more likely to have control 460 
problems than older dogs [59]. This is due to higher cortical centres in the brain developing 461 
with age and experience, resulting in increasingly inhibited pathways from these centres that 462 
inhibit the immediate behavioural response to emotions [60]. This study found no effect of age 463 
on the levels of excitability and chasing. There were also no effects of factors such as sex, 464 
neuter status, age, breed or reported level of AED side effects (sedation and ataxia) on these 465 
behavioural factors. Previous larger scale studies have demonstrated differences in C-BARQ 466 
factors by breed for example [61], and due to the relatively low sample size of this study, a 467 
larger sample may be required to allow the detection of such effects. The lack of effect of 468 
seizure frequency on ADHD-related behavioural factors in both the placebo and MCTD phases 469 
supports previous research in this area demonstrating that seizure activity is not essential for 470 
the presence comorbid ADHD-like behaviours. Dogs with BFJE demonstrated ADHD-like 471 
behaviours more than four years after their last observed seizure, which demonstrates that 472 
behavioural comorbidities can be present in the absence of seizure activity. 473 
 474 
Data from cross-fostering studies have demonstrated that the behavioural profiles of Fast and 475 
Slow rats are likely genetic or prenatal, and not likely to be due to the postnatal environment, 476 
with behaviour phenotypes in-line with their strain exhibited even if reared by a mother of the 477 
opposite strain, which show distinct maternal behaviours [62]. Genetic studies and longitudinal 478 
studies of behaviour are required to determine whether this also applies to dogs with epilepsy.  479 
External influences, for example the degree and type of training method used by the owner [59] 480 
may influence these behavioural factors associated with ADHD, as owners may perceive these 481 
behaviours as undesirable and aim to improve them through behavioural modification 482 
techniques. This is an inherent limitation of working with owned companion dogs rather than 483 
kennel-housed dogs living in a controlled setting, reflecting a real world situation. Larger scale 484 
future studies should attempt to quantify the degree of training that a dog has had to determine 485 
its influence on behaviour.  486 
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 487 
5. Conclusions 488 
 489 
Our data suggest that dogs with IE may exhibit similar signs of ADHD found in children with 490 
epilepsy, and rat models of epilepsy. These results corroborate previous findings of ADHD-491 
like behaviours observed in the Lagotto Romagnolo, but in a variety of breeds. The use of the 492 
MCTD reduced one of these ADHD-related behaviours, chasing, and reduced stranger related 493 
fear, and thus may have anxiolytic properties. Further studies are required to corroborate the 494 
relationship between epilepsy and ADHD in dogs, using ADHD specific rating scales (e.g. 495 
[20]) or objective behavioural testing to confirm these results in a larger mixed-breed sample 496 
of dogs. Further investigations using the similarities between human and dogs may increase 497 
our understanding of epilepsy and its comorbidities, benefitting both species. 498 
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Table 1 Comparison of behavioural scores for C-BARQ behavioural factors between a 
placebo and MCTD diet. Significant reductions were observed in the behavioural factors 
chasing and stranger directed fear (p<0.05). 
Behaviour Factor 
Diet (Mean ± SE) 
Wilcoxon results 
Placebo MCTD 
Stranger directed aggression 0.305 ± 0.145 0.210 ± 0.131 W=25.5, P=0.290 
Owner directed aggression 0.119 ± 0.080 0.030 ± 0.019 W=13.5, P=0.104 
Stranger directed fear 0.498 ± 0.203 0.313 ± 0.142 W=15.0, P=0.042 
Non-social fear 0.296 ± 0.082 0.323 ± 0.082 W=25.5, p=0.051 
Dog directed fear or aggression 0.392 ± 0.137 0.292 ± 0.110 W=29.0, p=0.123 
Separation related behaviour 0.321 ± 0.100 0.300 ± 0.097 W=53.0, p=0.600 
Attachment/attention-seeking behaviour 1.320 ± 0.131 1.30 ± 0.139 W=98.0, p=0.904 
Trainability 0.437 ± 0.125 0.600 ± 0.130 W=79.0, p=0.205 
Chasing 1.824 ± 0.210 1.516 ± 0.200 W=115.5, p=0.037 
Excitability 1.91 ± 0.127 1.863 ±0.136 W=112.0, p=0.794 
Pain sensitivity 0.458 ± 0.144 0.246 ± 0.101 W=35.0, p=0.444 
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Figure 1 Comparison of behavioural scores for C-BARQ behavioural factors between a 
placebo and MCTD diet. Significant reductions were observed in the behavioural factors 
chasing and stranger directed fear (p<0.05). 
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Supplementary Table C-BARQ behavioural questionnaire used to quantify eleven behavioural factors during the MCTD and placebo diet  
Does your dog ever react aggressively to the following situations Factor Rating 
1. When approached directly by an unfamiliar male adult while being walked or exercised on a lead 
Stranger directed aggression Never (0) 
Seldom (1) 
Sometimes (2) 
Usually (3) 
Always (4) 
 
2. When approached directly by an unfamiliar female adult while being walked or exercised on a lead 
3. When approached directly by an unfamiliar child while being walked or exercised on a lead 
4. Toward unfamiliar persons approaching the dog while it is in the owner’s car 
5. When an unfamiliar person approaches the owner or a member of the owner’s family at home 
6. When an unfamiliar person approaches the owner or a member of the owner’s family away from home 
7. When mailmen or other delivery workers approach the home 
8. When strangers walk past the home while the dog is in the garden 
9. When joggers, cyclists, roller skaters, or skateboarders pass the home while the dog is in the garden 
10. Toward unfamiliar persons visiting the home 
11. Toward unfamiliar dog visiting the home  
12. When approached directly by an unfamiliar dog of the same or larger size Dog directed fear or 
aggression 
13. When approached directly by an unfamiliar dog of a smaller size  
Does your dog ever respond aggressively to the following situations Factor Rating 
1. When verbally corrected or punished by a member of the household 
Owner directed aggression 
Never (0) 
Seldom (1) 
Sometimes (2) 
Usually (3) 
Always (4) 
 
2. When toys, bones, or other objects are taken away by a member of the household 
3. When bathed or groomed by a member of the household 
4. When approached directly by a member of the household while it is eating 
5. When food is taken away by a member of the household 
6. When stared at directly by a member of the household 
7. When stepped over by a member of the household 
8. When a member of the household retrieves food or objects stolen by the dog 
Please assess the following situations and determine how likely your dog is to respond in a fearful or anxious way Factor Rating 
1. When approached directly by an unfamiliar male adult while away from the home 
Stranger directed fear 
Never (0) 
Seldom (1) 2. When approached directly by an unfamiliar female adult while away from the home 
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3. When approached directly by an unfamiliar child while away from the home Sometimes (2) 
Usually (3) 
Always (4) 
4. When unfamiliar persons visit the home 
5. In response to sudden or loud noises 
Non-social fear 
6. In heavy traffic 
7. In response to strange or unfamiliar objects on or near the pavement 
8. During thunderstorms 
9. When first exposed to unfamiliar situations 
10. In response to wind or wind-blown objects 
Does your dog display the following behaviour? Factor Rating 
1. Shaking, shivering, or trembling when left or about to be left on its own 
Separation related behaviour 
Never (0) 
Seldom (1) 
Sometimes (2) 
Usually (3) 
Always (4) 
 
2. Excessive salivation when left or about to be left on its own 
3. Restlessness, agitation, or pacing when left or about to be left on its own 
4. Whining when left or about to be left on its own 
5. Barking when left or about to be left on its own 
6. Howling when left or about to be left on its own 
7. Chewing or scratching at doors, floor, windows, and curtains when left or about to be left on its own 
8. Loss of appetite when left or about to be left on its own 
Which category best describes your dog’s behaviour? Factor Rating 
1. Displays a strong attachment for a particular member of the household 
Attachment/attention seeking 
behaviour 
Never (0) 
Seldom (1) 
Sometimes (2) 
Usually (3) 
Always (4) 
2. Tends to follow a member of household from room to room about the house 
3. Tends to sit close to or in contact with a member of the household when that individual is sitting down 
4. Tends to nudge, nuzzle, or paw a member of the household for attention when that individual is sitting down. 
5. Becomes agitated when a member of the household shows affection for another person 
6. Becomes agitated when a member of the household shows affection for another dog or animal 
7. Returns immediately when called while off leash 
Trainability 
8. Obeys a sit command immediately 
9. Obeys a stay command immediately 
10. Will fetch or attempt to fetch sticks, balls, and other objects 
11. Seems to attend to or listen closely to everything the owner says or does 
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12. Is slow to respond to correction or punishment 
13. Is slow to learn new tricks or tasks 
14. Is easily distracted by interesting sights, sounds, or smells 
15. Acts aggressively toward cats, squirrels, and other animals entering its garden 
Chasing 
16. Chases cats if given the chance 
17. Chases birds if given the chance 
18. Chases squirrels and other small animals if given the chance 
19. Tends to nudge, nuzzle, or paw a member of the household for attention when that individual is sitting down. 
Does your dog respond in a highly excitable way to the following situations? Factor Rating 
1. When a member of the household returns home after a brief absence 
Excitability 
Never (0) 
Seldom (1) 
Sometimes (2) 
Usually (3) 
Always (4) 
2. When playing with a member of the household 
3. When the doorbell rings 
4. Just before being taken for a walk 
5. Just before being taken on a car trip 
6. When visitors arrive at its home 
Does your dog react in a fearful or anxious way to the following situations? Factor Rating 
1. When examined or treated by a veterinarian 
Pain sensitivity 
Never (0) 
Seldom (1) 
Sometimes (2) 
Usually (3) 
Always (4) 
2. When having its claws clipped by a household member 
3. When groomed or bathed by a household member 
 
 
